Skip to main content

Table 2 Protocol for gadoxetic acid-enhanced liver MRI (EOB-MRI)

From: Can preoperative liver MRI with gadoxetic acid help reduce open-close laparotomies for curative intent pancreatic cancer surgery?

Image sequence

Field strengths

TR (ms)

TE (ms)

FA (D°)

FOV (mm)

ST (mm)

Voxel size (mm)

Fat suppression

Respiratory control

Axial T2 HASTE

1.5 T

1200

180

160

400

5

1.3 × 1.3 × 5.0

SPAIR

Breath-hold

3 T

1200

181

146

380

5

1.2 × 1.2 × 5.0

Coronal T2 HASTE

1.5 T

1200

180

160

400

4

1.3 × 1.3 × 4.0

None

Breath-hold

3 T

1600

180

160

380

4

1.2 × 1.2 × 4.0

Axial T1 VIBE opp phase

1.5 T

178

2.22-4.60

70

380

4

0.7 × 0.7 × 4.0

None

Breath-hold

3 T

150

1.23-2.46

70

380

4

0.7 × 0.7 × 4.0

ep2d diff b100,600

1.5 T

5600

63.0

–

440

5

1.1 × 1.1 × 5.0

SPAIR

Off

3 T

6100

68.0

–

400

5

1.0 × 1.0 × 5.0

Axial T1 VIBE

1.5 T

4.07

1.92

10

420

3

1.3 × 1.3 × 3.0

SPAIR

Breath-hold

3 T

3.60

1.75

9

380

3

1.2 × 1.2 × 3.0

Post-contrast imaginga

 

Axial T1 VIBE

(late arterial phase)

1.5 T

4.07

1.92

10

420

3

1.3 × 1.3 × 3.0

SPAIR

Breath-hold

3 T

3.60

1.75

9

380

3

1.2 × 1.2 × 3.0

SPAIR

Breath-hold

Axial T1 VIBE

(portal venous phase)

1.5 T

4.07

1.92

10

420

3

1.3 × 1.3 × 3.0

SPAIR

Breath-hold

3 T

3.60

1.75

9

380

3

1.2 × 1.2 × 3.0

SPAIR

Breath-hold

Axial T1 VIBE (transitional phase)

1.5 T

4.07

1.92

10

420

3

1.3 × 1.3 × 3.0

SPAIR

Breath-hold

3 T

3.60

1.75

9

380

3

1.2 × 1.2 × 3.0

SPAIR

Breath-hold

Axial T1 VIBE 20 min (hepatobiliary phase)

1.5 T

4.97

2.01

25

400

3

1.3 × 1.3 × 3.0

SPAIR

Breath-hold

3 T

4.29

1.82

25

360

3

1.1 × 1.1 × 3.0

Coronal T1 VIBE 20 min

1.5 T

4.29

2.01

25

400

3

1.3 × 1.3 × 3.0

SPAIR

Breath-hold

3 T

4.42

1.77

25

400

3

1.3 × 1.3 × 3.0

Axial T1 CAIPI-VIBE 20 min (hepatobiliary phase)

1.5 T

6.63

TE1 = 2.36

TE2 = 4.77

9

360

1.5

1.1 × 1.1 × 1.5

None

Breath-hold

3 T

4.02

TE1 = 1.32

TE2 = 2.55

9

360

1.5

1.1 × 1.1 × 1.5

  1. aPatients received Gadoxetic acid (Primovist or Eovist, Bayer AG, Germany) intravenously through a 22-gauge intravenous catheter inserted into a forearm vein with an MR-compatible power injector (Medrad® Spectris Solaris® EP MR Injection system, Bayer Healthcare, Whippany, USA) at a rate of 1 mL/s (0.025 mmol/kg body weight) followed by a 10-mL normal saline chaser at the same rate
  2. FA Flip angle, FOV Field of view, SPAIR Spectral Attenuated Inversion Recovery, ST Section thickness, TE Echo time, TR Repetition time
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us